[Answered] The Greeks and the Romans, Indo-European speakers, derived their alphabet from the Semitic-speaking ...

This topic contains a solution. Click here to go to the answer

Author Question: The Greeks and the Romans, Indo-European speakers, derived their alphabet from the Semitic-speaking ... (Read 60 times)

Tazate

Hero Member
Posts: 532

on: Sep 12, 2019

Question 1

The policies of Darius tended to widen the gap between the king and his subjects.

a. True
b. False
Indicate whether the statement is true or false

Question 2

The Greeks and the Romans, Indo-European speakers, derived their alphabet from the Semitic-speaking Phoenicians.

a. True
b. False
Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

AISCAMPING

Sr. Member
Posts: 347

Reply #1 on: Sep 12, 2019

Answer 1

TRUE

Answer 2

TRUE

Tazate

Member
Posts: 532

Reply 2 on: Sep 12, 2019

Wow, this really help

Dinolord

Member
Posts: 313

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.